<DOC>
	<DOC>NCT01405911</DOC>
	<brief_summary>This study is being done to evaluate the safety, efficacy, and dose level of sitagliptin (MK-0431/ONO-5435) used once daily (qd) for Japanese subjects with impaired glucose tolerance who have inadequate glycemic control using diet and exercise therapy.</brief_summary>
	<brief_title>Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Impaired glucose tolerance On diet/exercise therapy Unlikely to conceive Meets all of the following glycemic parameters: Hemoglobin A1c (Japan Diabetes Society value) &lt;6.1%, Fasting Plasma Glucose &lt;126 mg/dL, and 2hr plasma glucose level in 75g oral glucose tolerance test â‰¥140 mg/dL and &lt;200 mg/dL History of diabetes mellitus Disease or condition of clear or likely glucose tolerance disorder Previously treated with a drug to prevent diabetes and/or any antihyperglycemic drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>